PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, Keio University School of Medicine, Tokyo, Japan.\', \'Center for Medical Genetics, Keio University School of Medicine, 5 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.\', \'Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Biotechnology, Graduate School of Engineering, Osaka University, Osaka, Japan.\', \'Exploratory Research Center On Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Japan.\', \'Institute for Integrated Radiation and Nuclear Science, Kyoto University, Osaka, Japan.\', \'Department of Molecular Biology, Keio University School of Medicine, Tokyo, Japan.\', \'Division of Infection Diseases and Infection Control, Keio University Hospital, Tokyo, Japan.\', \'Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.\', \'U-Medico, Inc., Osaka, Japan.\', \'Division of Gene Regulation, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.\', \'Department of Biochemistry, Keio University School of Medicine, Tokyo, Japan. gasbiology@keio.jp.\', \'Center for Medical Genetics, Keio University School of Medicine, 5 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. kkosaki@keio.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-05424-3
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35079088
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35079088>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35079088>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all